Teva Pharmaceutical Industries Limited (NYSE:TEVA) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) lost -0.08 Percent and closed its previous trading session at $23.73. The stock traded with the average Volume of 11.44 Million at the end of last session.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has the Market Capitalization of 24.76 Billion. The Stock has its 52-week High of $33.82 and 52-Week Low of $10.85 and it touched its 52-week high on 07/14/17 and 52-Week Low on 11/02/17
The company reported its last earnings Actual EPS of $0.94/share. While, the analyst predicted that the company could provide an EPS of $0.67/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.27/share which shows an Earnings Surprise of 40.3 Percent.
Sell side analysts plays vital role in buying and selling a stock where 1 analysts rated Teva Pharmaceutical Industries Limited (NYSE:TEVA) as Buy, 0 analysts given Outperform signal, 8 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.46% where SMA50 and SMA200 are 7.4% and 28.27% respectively.
The company shows its Return on Assets (ROA) value of -20.6%. The Return on Equity (ROE) value stands at -82.2%. While it’s Return on Investment (ROI) value is -36%.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) currently has a Weekly Volatility of 1.81% percent while its Monthly Volatility is at 2.88% percent. While talking about Performance of the Stock, Teva Pharmaceutical Industries Limited currently has a Weekly performance of -0.79%, monthly performance percentage is -1.21 percent, Quarterly performance is 30.53 percent, 6 months performance shows a percent value of 18.41% and Yearly Performance is -26.05 percent.
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.